Delavirdine (DLV) (brand name Rescriptor) is a non-nucleoside reverse transcriptase inhibitor (NNRTI) marketed by ViiV Healthcare. It is used as part...
7 KB (503 words) - 22:47, 5 August 2024
Amprenavir (HIV protease inhibitor) Darunavir (HIV protease inhibitor) Delavirdine (non-nucleoside reverse transcriptase inhibitor) Fosamprenavir (HIV protease...
4 KB (260 words) - 16:19, 11 August 2024
with, among other drugs: sucralfate ampicillin bisacodyl clopidogrel delavirdine fluvoxamine iron salts voriconazole aminophylline and theophylline astemizole...
17 KB (1,170 words) - 17:34, 29 August 2024
certain azole antifungals (e.g., ketoconazole, itraconazole, voriconazole) delavirdine, efavirenz, or a 5-HT1 receptor agonist (e.g., sumatriptan). Side effects...
23 KB (1,405 words) - 03:19, 13 September 2024
revoked in September 2016. Abacavir Amprenavir Atazanavir Darunavir Delavirdine Didanosine (ddI) Dolutegravir Efavirenz Enfuvirtide Stavudine (d4T) Etravirine...
26 KB (1,685 words) - 02:08, 21 February 2024
Retrovir and AZT) Non-nucleoside reverse transcriptase inhibitors (NNRTIs): delavirdine (brand name Rescriptor, no longer available) Attachment inhibitors fostemsavir...
8 KB (606 words) - 01:32, 26 July 2024
contraindicated in HIV positive patients taking protease inhibitors, delavirdine, and efavirenz (which is also an agonist at the 5-HT2A–mGlu2 receptor...
16 KB (1,144 words) - 07:19, 25 June 2024
Trimazosin Umespirone Zalospirone Pyridinylpiperazines Atevirdine Azaperone Delavirdine Mirtazapine ORG-12962 Pyridinylpiperazine Benzo(iso)thiazolylpiperazines...
83 KB (7,403 words) - 01:10, 7 September 2024
(Daklinza) Hepatitis C NS5A inhibitor Darunavir HIV antiretroviral HIV PI Delavirdine HIV antiretroviral NNRTI Descovy (Emtricitabine/tenofovir alafenamide)...
13 KB (513 words) - 14:31, 4 May 2024
Trimazosin Umespirone Zalospirone Pyridinylpiperazines Atevirdine Azaperone Delavirdine Mirtazapine ORG-12962 Pyridinylpiperazine Benzo(iso)thiazolylpiperazines...
27 KB (2,799 words) - 16:57, 21 August 2024